Overview

Skip to main content

Contact Us

Overview

Media Contact

Erin Murphy

media@mirumpharma.com
510-508-6521

Investor Contacts

Andrew McKibben

ir@mirumpharma.com
650-667-4085

Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Mirum Pharma, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Mirum Pharma to send you the requested Investor Email Alert updates.

* Required

Your Email *

Investor Alert Options

Investor Alert Options *

News
Quarterly Reports
Annual Reports
SEC Filings
End of Day Stock Quote
Events & Presentations

Unsubscribe

Email Alert Sign Up Confirmation

Investor Contacts

Andrew McKibben

650-667-4085
ir@mirumpharma.com

Media Contact

Erin Murphy

510-508-6521
media@mirumpharma.com

Quick Links

SEC Filings
Investor FAQs
Governance Documents

Privacy Policy
Terms of Use
Contact Us
CA TISCAD

© Mirum Pharmaceuticals Inc. - All rights reserved

Powered By Q4 Inc. 5.142.0.2 (opens in new window)